首页> 外文期刊>BJU international >Expression of E-series prostaglandin (EP) receptors and urodynamic effects of an EP4 receptor antagonist on cyclophosphamide-induced overactive bladder in rats.
【24h】

Expression of E-series prostaglandin (EP) receptors and urodynamic effects of an EP4 receptor antagonist on cyclophosphamide-induced overactive bladder in rats.

机译:EP4受体拮抗剂对大鼠环磷酰胺诱导的环磷酰胺诱导的过热膀胱的表达和尿动动力学效应。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To investigate the expression of four subtypes of E-series prostaglandin (EP(1) -EP(4) ) receptors and the urodynamic effects of an EP(4) receptor antagonist (AH23848) in cyclophosphamide (CYP)-induced overactive bladder (OAB) in rats, as intravesical prostaglandin E(2) (PGE(2) ) induces OAB via activation of EP receptors and sensitization of afferent nerves. MATERIALS AND METHODS: Experimental and control rats were injected with CYP (200 mg/kg, intraperitoneally) or saline, respectively. Continuous cystometrograms (CMGs) were performed 48 h after CYP or saline injection under urethane anaesthesia. AH23848 was given intravenously at doses of 0.01 and 0.1 mg/kg. The bladder was then harvested for histology. Some bladders were harvested for analysis of EP receptors expression by Western blotting without a CMG study. CMG variables (baseline pressure; intercontraction interval [ICI], pressure threshold [PT], contraction amplitude) and histological changes were measured. RESULTS: CYP-induced up-regulation of EP(4) receptor (100% increase) accompanied by detrusor overactivity (ICI 70.5% decrease; PT, 67.7% increase). However, CYP down-regulated EP(1) receptor expression (51.9% decrease), but had no significant effects on the EP(2) and EP(3) receptors. AH23848 significantly extended the ICI in CYP-treated rats but it had no effects on other urodynamic variables or in control rats. CONCLUSIONS: Modulation of EP receptors plays a role in CYP-induced OAB. Antagonists to the EP(4) receptor may be a new target for treatment of patients with OAB.
机译:目的:探讨e系列前列腺素(EP(1)-EP(4))受体的四种亚型的表达及其在环磷酰胺(CYP)中的EP(4)受体拮抗剂(AH23848)的尿动力学效应 - 诱导的过活性囊(OAB)在大鼠中,如膀胱内前列腺素E(2)(PGE(2))通过激活EP受体和传入神经的致敏诱导OAb。材料和方法:分别用CYP(200mg / kg,腹膜内)或盐水注射实验和对照大鼠。在氨基甲酸酯麻醉下CYP或盐水注射后,在CYP或盐水注射后进行连续胱芯图(CMG)。 AH23848以0.01和0.1mg / kg的剂量静脉内给药。然后收获膀胱以用于组织学。收获一些膀胱以分析EP受体表达,无CMG研究。测定CMG变量(基线压力;相互转换间隔,压力阈值[Pt],收缩幅度)和组织学变化。结果:CYP诱导EP(4)受体的上调(100%增加)伴有戒烟过效(ICI 70.5%降低; PT,67.7%增加)。然而,CYP下调的EP(1)受体表达(减少51.9%),但对EP(2)和EP(3)受体没有显着影响。 AH23848显着扩展了CYP处理的大鼠ICI,但它对其他尿动力学变量或对照大鼠没有影响。结论:EP受体的调节在CYP诱导的OAB中起作用。对拮抗剂(4)受体可以是治疗OAB患者的新靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号